,ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count
hsa04659,hsa04659,Th17 cell differentiation,19/73,108/8096,4.08E-20,3.01E-18,1.75E-18,916/915/3932/919/3561/917/3117/50615/3111/30009/3560/246778/3594/3123/3119/3122/3113/3115/3109,19
hsa04514,hsa04514,Cell adhesion molecules,19/73,149/8096,2.30E-17,5.17E-16,3.01E-16,926/201633/925/5133/914/3683/3117/29851/3111/80380/6693/3123/3119/3122/3113/3115/941/3689/3109,19
hsa04658,hsa04658,Th1 and Th2 cell differentiation,18/73,92/8096,5.84E-20,3.01E-18,1.75E-18,916/915/3932/919/3561/917/3117/3111/30009/3560/3594/3123/3119/3122/3113/3115/6775/3109,18
hsa04612,hsa04612,Antigen processing and presentation,13/73,78/8096,1.19E-13,1.02E-12,5.94E-13,926/925/3117/3111/3824/972/4261/3123/3119/3122/3113/3115/3109,13
hsa04650,hsa04650,Natural killer cell mediated cytotoxicity,13/73,131/8096,1.08E-10,5.86E-10,3.41E-10,3002/4068/5551/3932/919/3683/356/3824/962/5777/7409/3689/10870,13
hsa04660,hsa04660,T cell receptor signaling pathway,12/73,104/8096,1.02E-10,5.81E-10,3.38E-10,926/916/915/925/3932/919/5133/917/84433/29851/5777/7409,12
hsa05235,hsa05235,PD-L1 expression and PD-1 checkpoint pathway in cancer,7/73,89/8096,1.38E-05,4.60E-05,2.68E-05,916/915/3932/919/5133/917/5777,7
